학술논문
Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial
Document Type
Article
Author
Source
Bone Reports; October 2020, Vol. 13 Issue: 1, Number 1 Supplement 1
Subject
Language
ISSN
23521872